Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/02/2012CN101480415B Cordyceps sinensis sustained and controlled release capsule and preparation method thereof
05/02/2012CN101468958B Novel ethylene diamine derivative
05/02/2012CN101353378B Zone 2 protein of programmed cell death protein 2 analogue and uses thereof
05/02/2012CN101343265B Extraction method of effective ingredients of cave flower
05/02/2012CN101306128B Decoction for treating otitis media suppurativa acuta
05/02/2012CN101270160B Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody
05/02/2012CN101260098B Technique for preparing potassium sodium dehydroandroandrographolide succinate
05/02/2012CN101260097B Technique for preparing potassium sodium dehydroandroandrographolide succinic by using potassium dehydroandrographolide succinate
05/02/2012CN101104061B Decoction medicine for treating exterior-cold lung-attacked type pertussis and preparation method
05/02/2012CN101045156B Special target medicine and its use
05/01/2012US8168776 Method for making a 21 nucleotide double stranded RNA chemically linked at one end
05/01/2012US8168750 Subunits of the adenovirus fiber protein and uses thereof as vaccines
05/01/2012US8168748 Peptide aptamers that bind to the rep proteins of ssDNA viruses
05/01/2012US8168643 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
05/01/2012US8168641 Aspartyl protease inhibitors
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168622 β-lactamase-resistant cephalosporin ester compounds and salts of thereof
05/01/2012US8168583 2-fluoronucleosides
05/01/2012US8168418 Expression of HIV polypeptides and production of virus-like particles
05/01/2012US8168397 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
05/01/2012US8168207 Immunogenic proteins of leptospira
05/01/2012US8168205 Streptococcus pneumoniae polypeptides
05/01/2012US8168193 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168184 Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug
05/01/2012US8168179 Treatment method using anti-PD-L1 antibody
05/01/2012US8168176 CBLB for treating endotoxin-mediated disorders
05/01/2012CA2719512A1 Polymeric topical compositions
05/01/2012CA2556669C Hepatitis c inhibitor peptide analogs
05/01/2012CA2545307C Substituted dihydroquinazolines ii
05/01/2012CA2517888C Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
05/01/2012CA2493402C Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same
05/01/2012CA2475092C Nanoparticulate compositions having lysozyme as a surface stabilizer
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2456083C Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents
05/01/2012CA2455633C Sustained-release therapeutic bioadhesive systems
05/01/2012CA2450548C Method for the recombinant production of peptidic antiviral fusion inhibitors, and acetylation of gb41 fragments
05/01/2012CA2439928C Bacterial translocation inhibitor and method of inhibiting bacterial translocation
05/01/2012CA2438080C Gonococcal proteins and nucleic acids
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
04/2012
04/26/2012WO2012054874A1 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012WO2012054738A1 Combination of an aminoacyl - trna synthetase inhibitor with a further antibacterial agent for attenuating multiple drug resistance
04/26/2012WO2012054526A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012053917A1 Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition
04/26/2012WO2012053856A2 Respiratory syncytial virus vaccine composition and method for preparing same
04/26/2012WO2012053827A2 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
04/26/2012WO2012052956A1 Methods and compositions for treating pox virus infections with an 1, 4 -naphthoquinone as active agent
04/26/2012WO2012051912A1 Nitrogen-containing biphenyl compounds, pharmaceutical compositions of same, preparation methods and anti-hiv-1 uses thereof
04/26/2012WO2012051708A1 Anti-bacterial pyruvate kinase modulator compounds, compositions, uses, and methods
04/26/2012WO2012051663A1 Antimicrobial compounds
04/26/2012WO2012051659A1 Viral polymerase inhibitors
04/26/2012WO2012004684A3 Guanidinylated aminoglycoside -lipid conjugates
04/26/2012WO2011159129A3 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
04/26/2012WO2011156337A3 Macrocyclic hepatitis c serine protease inhibitors
04/26/2012WO2011047466A8 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
04/26/2012WO2011031926A8 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof
04/26/2012WO2000053787A9 Prrsv vaccines
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101277 Crystalline form of posaconazole
04/26/2012US20120101166 Composition and method for irrigation of a prepared dental root canal
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101157 4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof
04/26/2012US20120101140 Econazole Composition and Methods of Treatment Therewith
04/26/2012US20120101139 Econazole Composition and Methods of Treatment Therewith
04/26/2012US20120101138 Fluorinated aminotriazole derivatives
04/26/2012US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101100 Heterocyclic urea derivatives and methods of use thereof-211
04/26/2012US20120101098 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
04/26/2012US20120101095 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
04/26/2012US20120101091 Viral polymerase inhibitors
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101083 S1p1 agonists comprising a bicyclic n-containing ring
04/26/2012US20120101080 Composition for treatment of tuberculosis
04/26/2012US20120101076 Carbonate derivatives for the treatment of cough
04/26/2012US20120101070 11a, 12-Derivatives of Tetracycline Compounds
04/26/2012US20120101068 Diphenyl sulfide derivatives and medicines containing same as active ingredient
04/26/2012US20120101059 Sulphated hyaluronic acids as regulator agents of the cytokine activity
04/26/2012US20120101056 Medicinal Cream Made Using Framycetin Sulphate and Chitosan and a Process to Make the Same
04/26/2012US20120101055 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
04/26/2012US20120101052 15-thia steroid compounds and compositions
04/26/2012US20120101049 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral Administration
04/26/2012US20120101032 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012US20120101031 Macrocyclic hepatitis c serine protease inhibitors
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120100234 Non-occluding nasal moisturizer and methods of use
04/26/2012US20120100224 Compositions Against Rotavirus Infection and Processes For Producing The Same
04/26/2012US20120100200 System And Method For Satellite Drug Delivery
04/26/2012US20120100199 Method for treating a periodontal disease
04/26/2012US20120100197 Novel esters, and use thereof
04/26/2012US20120100186 Nanoparticulate-based contraceptive/anti-hiv composition and methods
04/26/2012US20120100181 Attenuation of Encephalitogenic Alphavirus and Uses Thereof
04/26/2012US20120100180 Methods for proliferation of antigen-specific t cells
04/26/2012US20120100178 Compositions And Methods For Treatment Of Microbial Infections
04/26/2012US20120100177 Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof
04/26/2012US20120100176 Different serotypes of vesicular stomatitis virus as expression vectors for immunization regimens
04/26/2012US20120100174 Composition comprising sortase anchored surface proteins of streptococcus uberis
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1798